Waverly Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.6M | Buy |
41,386
+7,344
| +22% | +$2.62M | 0.11% | 187 |
|
|
2025
Q4 | $11.1M | Buy |
34,042
+2,031
| +6% | +$644K | 0.09% | 217 |
|
|
2025
Q3 | $9.03M | Sell |
32,011
-439
| -1% | -$127K | 0.09% | 214 |
|
|
2025
Q2 | $9.06M | Buy |
32,450
+119
| +0.4% | +$33.7K | 0.1% | 204 |
|
|
2025
Q1 | $10.1M | Buy |
32,331
+1,317
| +4% | +$389K | 0.12% | 182 |
|
|
2024
Q4 | $8.08M | Buy |
31,014
+4,703
| +18% | +$1.4M | 0.13% | 161 |
|
|
2024
Q3 | $8.48M | Buy |
26,311
+2,699
| +11% | +$883K | 0.16% | 141 |
|
|
2024
Q2 | $7.38M | Buy |
23,612
+13,984
| +145% | +$4.11M | 0.14% | 143 |
|
|
2024
Q1 | $2.74M | Buy |
9,628
+3,393
| +54% | +$993K | 0.06% | 216 |
|
|
2023
Q4 | $1.8M | Sell |
6,235
-297
| -5% | -$80.9K | 0.07% | 161 |
|
|
2023
Q3 | $1.76M | Buy |
6,532
+892
| +16% | +$223K | 0.08% | 151 |
|
|
2023
Q2 | $1.25M | Buy |
5,640
+4,524
| +405% | +$1.05M | 0.05% | 164 |
|
|
2023
Q1 | $270K | Sell |
1,116
-79
| -7% | -$19.4K | 0.01% | 250 |
|
|
2022
Q4 | $314K | Sell |
1,195
-62
| -5% | -$16.6K | 0.02% | 217 |
|
|
2022
Q3 | $283K | Buy |
1,257
+101
| +9% | +$24.5K | 0.02% | 200 |
|
|
2022
Q2 | $281K | Buy |
1,156
+51
| +5% | +$12.5K | 0.03% | 170 |
|
|
2022
Q1 | $267K | Buy |
1,105
+41
| +4% | +$9.42K | 0.02% | 166 |
|
|
2021
Q4 | $243K | Sell |
1,064
-264
| -20% | -$55.7K | 0.02% | 181 |
|
|
2021
Q3 | $281K | Buy |
1,328
+198
| +18% | +$45.6K | 0.02% | 176 |
|
|
2021
Q2 | $260K | Buy |
1,130
+1
| +0.1% | +$246 | 0.02% | 164 |
|
|
2021
Q1 | $284K | Buy |
+1,129
| New | +$269K | 0.03% | 140 |
|
|
2020
Q3 | – | Sell |
-867
| Closed | -$208K | – | 145 |
|
|
2020
Q2 | $208K | Buy |
+867
| New | +$198K | 0.03% | 143 |
|
|
2018
Q4 | – | Sell |
-2,592
| Closed | -$537K | – | 121 |
|
|
2018
Q3 | $537K | Buy |
2,592
+108
| +4% | +$21.3K | 0.08% | 117 |
|
|
2018
Q2 | $459K | Sell |
2,484
-92
| -4% | -$16.3K | 0.07% | 121 |
|
|
2018
Q1 | $439K | Sell |
2,576
-3,100
| -55% | -$569K | 0.07% | 123 |
|
|
2017
Q4 | $987K | Buy |
5,676
+3,105
| +121% | +$550K | 0.14% | 101 |
|
|
2017
Q3 | $479K | Sell |
2,571
-26
| -1% | -$4.61K | 0.1% | 137 |
|
|
2017
Q2 | $447K | Buy |
2,597
+1,015
| +64% | +$165K | 0.11% | 143 |
|
|
2017
Q1 | $260K | Buy |
+1,582
| New | +$263K | 0.07% | 182 |
|
|
2014
Q4 | – | Sell |
-52
| Closed | -$7K | – | 424 |
|
|
2014
Q3 | $7K | Sell |
52
-17
| -25% | -$2.22K | ﹤0.01% | 554 |
|
|
2014
Q2 | $8K | Sell |
69
-35
| -34% | -$4.05K | ﹤0.01% | 487 |
|
|
2014
Q1 | $13K | Sell |
104
-91
| -47% | -$11K | 0.01% | 379 |
|
|
2013
Q4 | $22K | Buy |
195
+52
| +36% | +$5.92K | 0.01% | 440 |
|
|
2013
Q3 | $16K | Buy |
+143
| New | +$15.5K | 0.01% | 381 |
|
Other funds holding AMGN
VCM
VPM
Waverly Advisors's AMGN Position: Q1 2026 in Review
Waverly Advisors increased its Amgen (AMGN) stake by 22% in Q1 2026, buying an estimated $2.62M and bringing the position to 41,386 shares worth $14.6M. The position accounts for 0.11% of the portfolio, ranked #187.
Waverly Advisors first reported a position in AMGN in Q3 2013 and has held it in 34 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Waverly Advisors held 41,386 shares of Amgen worth $14.6M as of Q1 2026.
- Waverly Advisors bought 7,344 Amgen shares in Q1 2026, an estimated $2.62M.
- Amgen made up 0.11% of Waverly Advisors's portfolio in Q1 2026, its #187 holding.
- Waverly Advisors first reported a position in Amgen in Q3 2013 and has held it in 34 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.